These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7581910)

  • 21. Presence of methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines, derivatives of the neurotoxin isoquinoline, in parkinsonian lumbar CSF.
    Moser A; Kömpf D
    Life Sci; 1992; 50(24):1885-91. PubMed ID: 1598074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolism and brain accumulation of tetrahydroisoquinoline (TIQ) a possible parkinsonism inducing substance, in an animal model of a poor debrisoquine metabolizer.
    Ohta S; Tachikawa O; Makino Y; Tasaki Y; Hirobe M
    Life Sci; 1990; 46(8):599-605. PubMed ID: 2308469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 4-phenylpyridine and three other analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine lack dopaminergic nigrostriatal neurotoxicity in mice and marmosets.
    Perry TL; Jones K; Hansen S; Wall RA
    Neurosci Lett; 1987 Mar; 75(1):65-70. PubMed ID: 3106859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of mitochondrial respiration by 1,2,3,4-tetrahydroisoquinoline-like endogenous alkaloids in mouse brain.
    Suzuki K; Mizuno Y; Yoshida M
    Neurochem Res; 1990 Jul; 15(7):705-10. PubMed ID: 1975653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resolution of catecholic tetrahydroisoquinoline enantiomers and the determination of R- and S-salsolinol in biological samples by gas chromatography-mass spectrometry.
    Haber H; Henklein P; Georgi M; Melzig MF
    J Chromatogr B Biomed Appl; 1995 Oct; 672(2):179-87. PubMed ID: 8581123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction of rat brain levels of the endogenous dopaminergic proneurotoxins 1,2,3,4-tetrahydroisoquinoline and 1,2,3,4-tetrahydro-beta-carboline by cigarette smoke.
    Soto-Otero R; Méndez-Alvarez E; Sánchez-Sellero I; Cruz-Landeira A; López-Rivadulla Lamas M
    Neurosci Lett; 2001 Feb; 298(3):187-90. PubMed ID: 11165438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Presence of tetrahydroisoquinoline, a parkinsonism-related compound, in foods.
    Niwa T; Yoshizumi H; Tatematsu A; Matsuura S; Nagatsu T
    J Chromatogr; 1989 Sep; 493(2):347-52. PubMed ID: 2584300
    [No Abstract]   [Full Text] [Related]  

  • 28. Reduction of 1-methyl 1,2,3,4-tetrahydroisoquinoline level in substantia nigra of the aged rat.
    Ayala A; Parrado J; Cano J; Machado A
    Brain Res; 1994 Feb; 638(1-2):334-6. PubMed ID: 8199872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The search for endogenous or exogenous MPTP-like substances].
    Nagatsu T
    Rinsho Shinkeigaku; 1989 Dec; 29(12):1497-500. PubMed ID: 2517047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel toxins and Parkinson's disease: N-methylation and oxidation as metabolic bioactivation of neurotoxin.
    Naoi M; Maruyama W; Niwa T; Nagatsu T
    J Neural Transm Suppl; 1994; 41():197-205. PubMed ID: 7931227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Capillary liquid chromatography-tandem mass spectrometry of tetrahydroisoquinoline derived neurotoxins: a study on the blood-brain barrier of rat brain.
    Song Y; Xu J; Hamme A; Liu YM
    J Chromatogr A; 2006 Jan; 1103(2):229-34. PubMed ID: 16310796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of complex I by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    McNaught KS; Thull U; Carrupt PA; Altomare C; Cellamare S; Carotti A; Testa B; Jenner P; Marsden CD
    Biochem Pharmacol; 1995 Nov; 50(11):1903-11. PubMed ID: 8615871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of a novel neurotoxic metabolite of Parkinson's disease-related neurotoxin, 1-benzyl-1,2,3,4- tetrahydroisoquinoline.
    Kotake Y; Sekiya Y; Okuda K; Ohta S
    J Toxicol Sci; 2014; 39(5):749-54. PubMed ID: 25242405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endogenous risk factors in Parkinson's disease: dopamine and tetrahydroisoquinolines.
    Antkiewicz-Michaluk L
    Pol J Pharmacol; 2002; 54(6):567-72. PubMed ID: 12866710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of 1,2,3,4-tetrahydroisoquinoline with some components of cigarette smoke: potential implications for Parkinson's Disease.
    Soto-Otero R; Riguera-Vega R; Méndez-Alvarez E; Sánchez-Sellero I; López-Rivadulla Lamas M
    Biochem Biophys Res Commun; 1996 May; 222(2):607-11. PubMed ID: 8670252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolism and penetration through blood-brain barrier of parkinsonism-related compounds. 1,2,3,4-Tetrahydroisoquinoline and 1-methyl-1,2,3,4-tetrahydroisoquinoline.
    Kikuchi K; Nagatsu Y; Makino Y; Mashino T; Ohta S; Hirobe M
    Drug Metab Dispos; 1991; 19(1):257-62. PubMed ID: 1673411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and neurotoxicity of tetrahydroisoquinoline derivatives for studying Parkinson's disease.
    Abe K; Saitoh T; Horiguchi Y; Utsunomiya I; Taguchi K
    Biol Pharm Bull; 2005 Aug; 28(8):1355-62. PubMed ID: 16079473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Tetrahydroisoquinolines in connection with Parkinson's disease].
    Ohta S
    Rinsho Shinkeigaku; 1989 Dec; 29(12):1504-6. PubMed ID: 2698297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The endogenous amine 1-methyl-1,2,3,4- tetrahydroisoquinoline prevents the inhibition of complex I of the respiratory chain produced by MPP(+).
    Parrado J; Absi E; Ayala A; Castaño A; Cano J; Machado A
    J Neurochem; 2000 Jul; 75(1):65-71. PubMed ID: 10854248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endogenous dopamine-derived neurotoxins and Parkinson's disease.
    Deleu D
    Acta Neurol Belg; 1998 Dec; 98(4):319-21. PubMed ID: 9922818
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.